Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Effectiveness of Virtual Reality Vision Therapy - VERVE
Early Phase 1
Recruiting
- Conditions
- Convergence Insufficiency
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- OculoMotor Technologies
- Target Recruit Count
- 50
- Registration Number
- NCT04691427
- Locations
- 🇺🇸
OculoMotor Technologies, Newark, New Jersey, United States
🇺🇸The Eye Institute at Salus University, Philadelphia, Pennsylvania, United States
News
No news found